Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27
Open Access
- 6 January 2004
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (1) , 182-188
- https://doi.org/10.1038/sj.bjc.6601449
Abstract
Heat shock protein 27 (hsp-27) is a regulator of oestrogen receptor (ER) expression and a modulator of intracellular homeostasis. In this laboratory, Shaaban et al demonstrated the importance of ER-α, together with Ki67, in enhancing the progression of benign breast lesions of defined morphological types. To better understand the mechanisms by which ER-α promotes breast neoplasia, this study was performed to test the hypothesis that the roles of ER-α and hsp-27 may be defined by their quantitative expression in proliferative breast lesions of varying histological risk. The expression of hsp-27 was identified using a specific monoclonal antibody and analysed to assess the proportion of positive epithelial cells using digitised morphometric image analysis. The expression of ER-α was analysed by immunohistochemistry and Western blotting in a variety of benign (HUMA121) and malignant mammary cell lines, including ER-α(+) (MCF7, ZR-75, T47D) and ER-α(−) (MDA-MB 231) breast cancer cell lines. The data confirm that, during progression from normal through proliferative breast lesions to in situ cancer, there was a significant increase in both the proportion and the optical density of the epithelial cells expressing hsp-27. The mean levels of expression ranged from 7.4% of the total number of epithelial cells in normal lobules to 25.17% of epithelial cells in hyperplasias of usual type (HUT) to 61.1% of epithelial cells in ductal carcinoma in situ (Pα(+) expression, and that its regulated expression occurs early along the mammary oncogenic pathway, supporting the initial hypothesis. It is our proposal that the differential expression of hsp-27 modulates the phenotypic behaviour of morphologically benign epithelial cells and hence may be an important determinant in initiating, or promoting, a population of human mammary cancers.Keywords
This publication has 32 references indexed in Scilit:
- Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolutionThe Journal of Pathology, 2001
- Murine Cells Transfected with Human Hsp27 cDNA Resist TNF-Induced CytotoxicityJournal of Immunotherapy, 1996
- Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing.Journal of Clinical Pathology, 1994
- Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.Journal of Histochemistry & Cytochemistry, 1993
- Stress Response Protein (srp-27) Determination in Primary Human Breast Carcinomas: Clinical, Histologic, and Prognostic CorrelationsJNCI Journal of the National Cancer Institute, 1991
- Evaluation of immunohistochemical staining of breast tissue by an oestrogen-regulated protein, 24K according to epidemiological and radiological breast cancer risk criteriaCancer Letters, 1990
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985
- Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7)Breast Cancer Research and Treatment, 1981
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980
- Estrogen induced synthesis of specific proteins in human breast cancer cellsBiochemical and Biophysical Research Communications, 1980